1-3 of 3
Rudy van Hemert
Close
Sort by
Journal Articles

Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma

Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold
Journal: Blood
Blood (2023) 142 (Supplement 1): 882.
https://doi.org/10.1182/blood-2023-180896
Published: 2023
Journal Articles

The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

Clinical Trials & Observations
Leo Rasche, Edgardo J. Angtuaco, Terri L. Alpe, Grant H. Gershner, James E. McDonald, Rohan S. Samant, Manoj Kumar, Rudy Van Hemert, Joshua Epstein, Shayu Deshpande, Ruslana Tytarenko, Shmuel Yaccoby, Jens Hillengass, Sharmilan Thanendrarajan, Carolina Schinke, Frits van Rhee, Maurizio Zangari, Brian A. Walker, Bart Barlogie, Gareth J. Morgan, Faith E. Davies, Niels Weinhold
Journal: Blood
Blood (2018) 132 (1): 59–66.
https://doi.org/10.1182/blood-2018-04-842880
Published: 2018
Includes: Supplemental data
Journal Articles

The Gene Expression Signatures (GEP) of Whole Bone Marrow Biopsies (Bx) from Patients with Multiple Myeloma (MM) in Remission Reflect Disease Risk and Therapy.

Fenghuang Zhan, MD, PhD, Yongsheng Huang, MS, Rudy Van Hemert, MD, Owen Stephens, BS, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD
Journal: Blood
Blood (2005) 106 (11): 1547.
https://doi.org/10.1182/blood.V106.11.1547.1547
Published: 2005